Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.

Utachee P, Isarangkura-na-ayuthaya P, Tokunaga K, Ikuta K, Takeda N, Kameoka M.

Retrovirology. 2014 Apr 23;11:32. doi: 10.1186/1742-4690-11-32.

PMID:
24758333
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials.

Yu B, Morales JF, O'Rourke SM, Tatsuno GP, Berman PW.

PLoS One. 2012;7(8):e43903. doi: 10.1371/journal.pone.0043903. Epub 2012 Aug 22.

PMID:
22928048
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon.

Etienne L, Locatelli S, Ayouba A, Esteban A, Butel C, Liegeois F, Aghokeng A, Delaporte E, Mpoudi Ngole E, Peeters M.

J Virol. 2012 Sep;86(18):9760-72. doi: 10.1128/JVI.01186-12. Epub 2012 Jun 27.

PMID:
22740419
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals.

Tomaras GD, Binley JM, Gray ES, Crooks ET, Osawa K, Moore PL, Tumba N, Tong T, Shen X, Yates NL, Decker J, Wibmer CK, Gao F, Alam SM, Easterbrook P, Abdool Karim S, Kamanga G, Crump JA, Cohen M, Shaw GM, Mascola JR, Haynes BF, Montefiori DC, Morris L.

J Virol. 2011 Nov;85(21):11502-19. doi: 10.1128/JVI.05363-11. Epub 2011 Aug 17.

PMID:
21849452
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals.

Tang H, Robinson JE, Gnanakaran S, Li M, Rosenberg ES, Perez LG, Haynes BF, Liao HX, Labranche CC, Korber BT, Montefiori DC.

J Virol. 2011 Sep;85(18):9286-99. doi: 10.1128/JVI.02286-10. Epub 2011 Jul 6.

PMID:
21734041
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumab.

Toma J, Weinheimer SP, Stawiski E, Whitcomb JM, Lewis ST, Petropoulos CJ, Huang W.

J Virol. 2011 Apr;85(8):3872-80. doi: 10.1128/JVI.02237-10. Epub 2011 Feb 2.

PMID:
21289125
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.

Etienne L, Nerrienet E, LeBreton M, Bibila GT, Foupouapouognigni Y, Rousset D, Nana A, Djoko CF, Tamoufe U, Aghokeng AF, Mpoudi-Ngole E, Delaporte E, Peeters M, Wolfe ND, Ayouba A.

Retrovirology. 2011 Jan 13;8:4. doi: 10.1186/1742-4690-8-4.

PMID:
21232091
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.

Utachee P, Nakamura S, Isarangkura-Na-Ayuthaya P, Tokunaga K, Sawanpanyalert P, Ikuta K, Auwanit W, Kameoka M.

J Virol. 2010 May;84(9):4311-20. doi: 10.1128/JVI.02619-09. Epub 2010 Feb 17.

PMID:
20164234
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC.

J Virol. 2009 Jul;83(14):7337-48. doi: 10.1128/JVI.00110-09. Epub 2009 May 13.

PMID:
19439467
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa.

Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, Robinson JE, Decker JM, Li Y, Salazar MG, Polonis VR, Mlisana K, Karim SA, Hong K, Greene KM, Bilska M, Zhou J, Allen S, Chomba E, Mulenga J, Vwalika C, Gao F, Zhang M, Korber BT, Hunter E, Hahn BH, Montefiori DC.

J Virol. 2006 Dec;80(23):11776-90. Epub 2006 Sep 13.

PMID:
16971434
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.

Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, Bilska M, Kothe DL, Salazar-Gonzalez JF, Wei X, Decker JM, Hahn BH, Montefiori DC.

J Virol. 2005 Aug;79(16):10108-25.

PMID:
16051804
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Messer RJ, Dittmer U, Peterson KE, Hasenkrug KJ.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12260-5. Epub 2004 Aug 5.

PMID:
15297622
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.

Ohagen A, Devitt A, Kunstman KJ, Gorry PR, Rose PP, Korber B, Taylor J, Levy R, Murphy RL, Wolinsky SM, Gabuzda D.

J Virol. 2003 Nov;77(22):12336-45.

PMID:
14581570
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk